NATS 1540 Chapter Notes - Chapter 3.2: Heparin-Induced Thrombocytopenia, Rivaroxaban, Fondaparinux
31 May 2020
School
Department
Course
Professor
Document Summary
Venous thromboembolism case learning objectives (suggested resources included in brackets) Briefly describe the role of each antithrombotic listed below in the management of vte (including a short description of efficacy). Develop a drug chart to compare and contrast the relevant pharmacokinetics, dosing, clinically important drug interactions, and monitoring parameters (including lab test): unfractionated heparin, summarize the clinical presentation of heparin induced thrombocytopenia. (accp guideline chapter, dipiro). Iv infusion vs. sc administration) fondaparinux: low molecular weight heparins, rivaroxaban, warfarin. Evaluate the efficacy of rivaroxaban for the treatment of vte ( einstein. Duration of therapy describe recommended duration of anticoagulation therapy in patients with venous thromboembolism. (accp guidelines) Warfarin initiation dosing: develop a response to case 1 on warfarin initiation therapy. Summarize a general approach for initiation dosing of warfarin. (accp guidelines) Warfarin maintenance dose: develop a response to case 2 & 3 on warfarin maintenance therapy. Supratherapeutic inrs - summarize the accp guidelines on the management of supratherapeutic.
